Evogene Ltd.
Stock Forecast, Prediction & Price Target
Evogene Ltd. Financial Estimates
Evogene Ltd. Revenue Estimates
Evogene Ltd. EBITDA Estimates
Evogene Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $930K N/A | $1.67M 80.10% | $5.64M 236.71% | Avg: $25.85M Low: $25.85M High: $25.85M avg. 358.33% | Avg: $47.27M Low: $47.27M High: $47.27M avg. 82.88% | Avg: $49.89M Low: $49.89M High: $49.89M avg. 5.53% | Avg: $68.06M Low: $68.06M High: $68.06M avg. 36.42% |
Net Income
% change YoY
| $-30.44M N/A | $-29.84M 1.97% | $-23.87M 19.98% | Avg: $-19.69M Low: $-15.98M High: $-15.07M avg. 17.52% | Avg: $-10.17M Low: $-6.62M High: $-6.62M avg. 48.33% | Avg: $-4.56M Low: $-4.56M High: $-4.56M avg. 55.10% | Avg: $456.85K Low: $456.85K High: $456.85K avg. 109.99% |
EBITDA
% change YoY
| $-26.78M N/A | $-23.84M 10.97% | $-23.20M 2.68% | Avg: $-25.85M Low: $-25.85M High: $-25.85M avg. -11.40% | Avg: $-47.27M Low: $-47.27M High: $-47.27M avg. -82.88% | Avg: $-49.89M Low: $-49.89M High: $-49.89M avg. -5.53% | Avg: $-68.06M Low: $-68.06M High: $-68.06M avg. -36.42% |
EPS
% change YoY
| -$0.75 N/A | -$0.72 4.00% | -$5.23 -626.38% | Avg: -$0.34 Low: -$0.35 High: -$0.33 avg. 93.49% | Avg: -$0.15 Low: -$0.15 High: -$0.15 avg. 57.35% | Avg: -$0.1 Low: -$0.1 High: -$0.1 avg. 31.03% | Avg: $0.01 Low: $0.01 High: $0.01 avg. 109.99% |
Operating Expenses
% change YoY
| $31.11M N/A | $27.70M -10.95% | $27.79M 0.29% | Avg: $133.64M Low: $133.64M High: $133.64M avg. 380.89% | Avg: $244.40M Low: $244.40M High: $244.40M avg. 82.88% | Avg: $257.92M Low: $257.92M High: $257.92M avg. 5.53% | Avg: $351.87M Low: $351.87M High: $351.87M avg. 36.42% |
FAQ
What is Evogene Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 57.73% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -15.98M, average is -19.69M and high is -15.07M.
What is Evogene Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 120.79% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $25.85M, average is $25.85M and high is $25.85M.
What is Evogene Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 72.97% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.35, average is -$0.34 and high is $-0.33.